Differences in κB DNA-binding properties of v-Rel and c-Rel are the result of oncogenic mutations in three distinct functional regions of the Rel protein

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Oncogene

• Publication date

  1997-06-19

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/sj.onc.1201150PMID 9205096
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Structure and expression of a chicken MHC class I gene

  2005cited by this paper
• The NF-kappa B and I kappa B proteins: new discoveries and insights.

  1996cited by this paper
• The v‐rel oncogene promotes malignant T‐cell leukemia/lymphoma in transgenic mice.

  1996cited by this paper
• NF-kappa B: ten years after.

  1996cited by this paper
• The Rel family of eukaryotic transcription factors.

  1996cited by this paper
• v-rel and c-rel induce a membrane protein, p75, on avian hematopoietic cells.

  1996cited by this paper
• The v-Rel oncoprotein blocks apoptosis and proteolysis of I kappa B-alpha in transformed chicken spleen cells.

  1995cited by this paper
• v-rel Induces ectopic expression of an adhesion molecule, DM-GRASP, during B-lymphoma development

  1995cited by this paper
• Structure of the NF-kappa B p50 homodimer bound to DNA.

  1995cited by this paper
• Mutations in the DNA-binding and dimerization domains of v-Rel are responsible for altered kappa B DNA-binding complexes in transformed cells

  1995cited by this paper
• The relocalization of v-Rel from the nucleus to the cytoplasm coincides with induction of expression of Ikba and nfkb1 and stabilization of I kappa B-alpha

  1995cited by this paper
• The DNA Provirus: Howard Temin's Scientific Legacy

  1995cited by this paper
• A mutant v-rel with increased ability to transform B lymphocytes

  1995cited by this paper
• Structure of NF-kappa B p50 homodimer bound to a kappa B site.

  1995cited by this paper
• Rel/NF-kappa B/I kappa B family: intimate tales of association and dissociation.

  1995cited by this paper
• DNA-binding proteins. A butterfly flutters by.

  1995cited by this paper
• The PEST-like sequence of I kappa B alpha is responsible for inhibition of DNA binding but not for cytoplasmic retention of c-Rel or RelA homodimers

  1995cited by this paper
• Avian I kappa B alpha is transcriptionally induced by c-Rel and v-Rel with different kinetics

  1995cited by this paper
• Interaction of the v-Rel oncoprotein with cellular transcription factor Sp1

  1994cited by this paper
• Evolution of the oncogenic potential of v-rel: rel-induced expression of immunoregulatory receptors correlates with tumor development and in vitro transformation

  1994cited by this paper
• Structure, regulation and function of NF-kappa B.

  1994cited by this paper
• Structural genes, not the LTRs, are the primary determinants of reticuloendotheliosis virus A-induced runting and bursal atrophy.

  1994cited by this paper
• v-rel induces expression of three avian immunoregulatory surface receptors more efficiently than c-rel

  1994cited by this paper
• Transformation of avian fibroblasts overexpressing the c-rel proto-oncogene and a variant of c-rel lacking 40 C-terminal amino acids

  1994cited by this paper
• In vivo evolution of c-rel oncogenic potential

  1994cited by this paper
• Function and activation of NF-kappa B in the immune system.

  1994cited by this paper
• Kappa B binding activity in a murine macrophage-like cell line. Sequence-specific differences in kappa B binding and transcriptional activation functions.

  1994cited by this paper
• Transcriptional regulation of NF-kappa B2: evidence for kappa B-mediated positive and negative autoregulation

  1994cited by this paper
• A novel NF-kappa B complex containing p65 homodimers: implications for transcriptional control at the level of subunit dimerization

  1993cited by this paper
• Two novel functions associated with the Rel oncoproteins: DNA replication and cell-specific transcriptional activation.

  1993cited by this paper
• Functional interaction of the v-Rel and c-Rel oncoproteins with the TATA-binding protein and association with transcription factor IIB

  1993cited by this paper
• Isolation of the chicken NF-kappa B p65 subunit-encoding cDNA and characterization of its products.

  1993cited by this paper
• Differential pp40I kappa B-beta inhibition of DNA binding by rel proteins

  1993cited by this paper
• The c-rel protooncogene product represses NF-kappa B p65-mediated transcriptional activation of the long terminal repeat of type 1 human immunodeficiency virus.

  1993cited by this paper
• Nuclear hormone receptors involved in neoplasia: erb A exhibits a novel DNA sequence specificity determined by amino acids outside of the zinc-finger domain

  1993cited by this paper
• I kappa B alpha-mediated inhibition of v-Rel DNA binding requires direct interaction with the RXXRXRXXC Rel/kappa B DNA-binding motif.

  1993cited by this paper
• Mutational analysis of the p50 subunit of NF-kappa B and inhibition of NF-kappa B activity by trans-dominant p50 mutants

  1993cited by this paper
• Transformation by the vRel oncoprotein requires sequences carboxy-terminal to the Rel homology domain.

  1993cited by this paper
• v-Rel and c-Rel are differentially affected by mutations at a consensus protein kinase recognition sequence.

  1993cited by this paper
• High levels of c-rel expression are associated with programmed cell death in the developing avian embryo and in bone marrow cells in vitro.

  1993cited by this paper
• NF-kappa B p100 is one of the high-molecular-weight proteins complexed with the v-Rel oncoprotein in transformed chicken spleen cells

  1993cited by this paper
• N-terminal DNA-binding domains contribute to differential DNA-binding specificities of NF-kappa B p50 and p65

  1993cited by this paper
• Temperature-sensitive transforming mutants of the v-rel oncogene

  1993cited by this paper
• Acquisition of NFKB1-selective DNA binding by substitution of four amino acid residues from NFKB1 into RelA

  1993cited by this paper
• Structural alterations of the NF-kappa B transcription factor lyt-10 in lymphoid malignancies.

  1993cited by this paper
• Both N- and C-terminal domains of RelB are required for full transactivation: role of the N-terminal leucine zipper-like motif

  1993cited by this paper
• Selection of optimal kappa B/Rel DNA-binding motifs: interaction of both subunits of NF-kappa B with DNA is required for transcriptional activation

  1992cited by this paper
• Mutations in the rel-homology domain alter the biochemical properties of v-rel and render it transformation defective in chicken embryo fibroblasts.

  1992cited by this paper
• The RxxRxRxxC motif conserved in all Rel/kappa B proteins is essential for the DNA-binding activity and redox regulation of the v-Rel oncoprotein

  1992cited by this paper
• Hormone‐regulated v‐rel estrogen receptor fusion protein: reversible induction of cell transformation and cellular gene expression.

  1992cited by this paper
• The Rel family: models for transcriptional regulation and oncogenic transformation.

  1992cited by this paper
• v-rel- and c-rel-protein complexes bind to the NF-kappa B site in vitro.

  1992cited by this paper
• I kappa B interacts with the nuclear localization sequences of the subunits of NF-kappa B: a mechanism for cytoplasmic retention.

  1992cited by this paper
• vRel is an inactive member of the Rel family of transcriptional activating proteins

  1991cited by this paper
• Oncogenic conversion by regulatory changes in transcription factors.

  1991cited by this paper
• Alterations at the rel locus in human lymphoma.

  1991cited by this paper
• The p65 subunit is responsible for the strong transcription activating potential of NF‐kappa B.

  1991cited by this paper
• The inducible transcription activator NF-kappa B: regulation by distinct protein subunits.

  1991cited by this paper
• Interaction of the v-rel protein with an NF-kappa B DNA binding site.

  1991cited by this paper
• A protein kinase-A recognition sequence is structurally linked to transformation by p59v-rel and cytoplasmic retention of p68c-rel

  1991cited by this paper
• B cell lymphoma-associated chromosomal translocation involves candidate oncogene lyt-10, homologous to NF-kappa B p50.

  1991cited by this paper
• Inhibition of transcription factors belonging to the rel/NF‐kappa B family by a transdominant negative mutant.

  1991cited by this paper
• Repression of the chicken c-rel promoter by vRel in chicken embryo fibroblasts is not mediated through a consensus NF-kappa B binding site.

  1991cited by this paper
• NF-kappa B, KBF1, dorsal, and related matters.

  1990cited by this paper
• Structure and autoregulation of the c-rel promoter.

  1990cited by this paper
• Mutational analysis of v-rel, the oncogene of reticuloendotheliosis virus strain T.

  1990cited by this paper
• Oncogenic transformation by vrel requires an amino-terminal activation domain

  1990cited by this paper
• The candidate proto-oncogene bcl-3 is related to genes implicated in cell lineage determination and cell cycle control.

  1990cited by this paper
• Cloning and expression of a chicken c-rel cDNA: unlike p59v-rel, p68c-rel is a cytoplasmic protein in chicken embryo fibroblasts.

  1990cited by this paper
• Characterization of a novel promoter insertion in the c-rel locus

  1990cited by this paper
• The N-terminal env-derived amino acids of v-rel are required for full transforming activity.

  1990cited by this paper
• The mouse c-rel protein has an N-terminal regulatory domain and a C-terminal transcriptional transactivation domain

  1990cited by this paper
• The v-rel oncogene encodes a kappa B enhancer binding protein that inhibits NF-kappa B function.

  1990cited by this paper
• Rapid detection of octamer binding proteins with 'mini-extracts', prepared from a small number of cells.

  1989cited by this paper
• Transactivation of gene expression by nuclear and cytoplasmic rel proteins

  1989cited by this paper
• Expression of the v-rel oncogene in reticuloendotheliosis virus-transformed fibroblasts.

  1988cited by this paper
• v-rel oncoproteins in the nucleus and in the cytoplasm transform chicken spleen cells

  1988cited by this paper
• Quantitative immunocytochemical assay for infectious avian retroviruses.

  1987cited by this paper
• High-efficiency transformation of mammalian cells by plasmid DNA.

  1987cited by this paper
• Activation of oncogenicity of the c-rel proto-oncogene

  1986cited by this paper
• Rapid and efficient site-specific mutagenesis without phenotypic selection.

  1985cited by this paper
• Cell lines derived from avian lymphomas exhibit two distinct phenotypes.

  1985cited by this paper
• Nucleic acid sequences of the oncogene v-rel in reticuloendotheliosis virus strain T and its cellular homolog, the proto-oncogene c-rel

  1984cited by this paper
• Substitution of 5' helper virus sequences into non-rel portion of reticuloendotheliosis virus strain T suppresses transformation of chicken spleen cells.

  1982cited by this paper
• Avian reticuloendotheliosis virus: identification of the hematopoietic target cell for transformation.

  1981cited by this paper
• The genomic RNA of avian reticuloendotheliosis virus REV.

  1980cited by this paper
• Transformation by reticuloendotheliosis virus: development of a focus assay and isolation of a nontransforming virus.

  1979cited by this paper

• Molecular Basis of Oncogenesis by NF-κB: From a Bird's Eye View to a RELevant Role in Cancer

  2013cites this paper
• Oncogenic Activation of c-Rel Nuclear Import and DNA Binding Enables -Mediated Control over α B κ Loss of I

  2012cites this paper
• Activation of the TGF-β/Smad signaling pathway in oncogenic transformation by v-Rel.

  2011cites this paper
• Cell transformation by v-Rel reveals distinct roles of AP-1 family members in Rel/NF-κB oncogenesis

  2010cites this paper
• ERK and JNK Activation is Essential for Oncogenic Transformation by v-Rel

  2010cites this paper
• Recognition of Nucleic Acids by Transcription Factor NF-κB

  2010cites this paper
• Regulation of Telomerase Activity by Interferon Regulatory Factors 4 and 8 in Immune Cells

  2008cites this paper
• An optimal range of transcription potency is necessary for efficient cell transformation by c-Rel to ensure optimal nuclear localization and gene-specific activation

  2007cites this paper
• The activation of TC10, a Rho small GTPase, contributes to v-Rel-mediated transformation

  2007cites this paper
• Molecular Basis of Oncogenesis by NF-κB

  2006cites this paper
• Divergent C-terminal transactivation domains of Rel/NF-κB proteins are critical determinants of their oncogenic potential in lymphocytes

  2004cites this paper
• Discreet mutations from c-Rel to v-Rel alter κB DNA recognition, IκBα binding, and dimerization: implications for v-Rel oncogenicity

  2004influential citation
• Discreet mutations from c-Rel to v-Rel alter kappaB DNA recognition, IkappaBalpha binding, and dimerization: implications for v-Rel oncogenicity.

  2004cites this paper
• The Rel/NF-κB/IκB Signal Transduction Pathway and Cancer

  2004cites this paper
• Distinct Pathways for NF-κB Regulation Are Associated with Aberrant Macrophage IL-12 Production in Lupus- and Diabetes-Prone Mouse Strains1

  2003cites this paper
• Viruses as Intruders in the Rel/NF-κB Signaling Pathway

  2003cites this paper
• Differential Regulation of the Inhibitor Of

  2002cites this paper
• Differential Regulation of the Inhibitor of Apoptosis ch-IAP1 by v-rel and the Proto-Oncogene c-rel

  2002cites this paper
• Mutational Analysis of the v-Rel Dimerization Interface Reveals a Critical Role for v-Rel Homodimers in Transformation

  2002cites this paper
• Aberrant Production of IL-12 by Macrophages from Several Autoimmune-Prone Mouse Strains Is Characterized by Intrinsic and Unique Patterns of NF-κB Expression and Binding to the IL-12 p40 Promoter1

  2002cites this paper
• A Novel Interferon Regulatory Factor (IRF), IRF-10, Has a Unique Role in Immune Defense and Is Induced by the v-Rel Oncoprotein

  2002cites this paper
• X-ray crystal structure of proto-oncogene product c-Rel bound to the CD28 response element of IL-2.

  2001cites this paper
• Three mutations in v-Rel render it resistant to cleavage by cell-death protease caspase-3.

  2001cites this paper
• The chicken RelB transcription factor has transactivation sequences and a tissue-specific expression pattern that are distinct from mammalian RelB.

  2001cites this paper
• The conserved redox-sensitive cysteine residue of the DNA-binding region in the c-Rel protein is involved in the regulation of the phosphorylation of the protein.

  2000cites this paper
• Mutant envelope residues confer a transactivation function onto N-terminal sequences of the v-Rel oncoprotein

  2000cites this paper
• Multiple mutations contribute to the oncogenicity of the retroviral oncoprotein v-Rel

  1999influential citation
• Mapping of a Serine-Rich Domain Essential for the Transcriptional, Antiapoptotic, and Transforming Activities of the v-Rel Oncoprotein

  1999cites this paper
• Expression of a dominant-negative mutant inhibitor-kappaBalpha of nuclear factor-kappaB in human head and neck squamous cell carcinoma inhibits survival, proinflammatory cytokine expression, and tumor growth in vivo.

  1999cites this paper
• Constitutive activation of transcription factors NF‐κB, AP‐1, and NF‐IL6 in human head and neck squamous cell carcinoma cell lines that express pro‐inflammatory and pro‐angiogenic cytokines

  1999cites this paper
• Expression of a Dominant-Negative Mutant Inhibitor-κBα of Nuclear Factor-κB in Human Head and Neck Squamous Cell Carcinoma Inhibits Survival, Proinflammatory Cytokine Expression, and Tumor Growth in Vivo

  1999cites this paper
• Regulation of DNA binding by Rel/NF-kappaB transcription factors: structural views.

  1999cites this paper
• Regulation of DNA binding by Rel/NF-κB transcription factors: structural views

  1999cites this paper
• Constitutive activation of transcription factors NF-(kappa)B, AP-1, and NF-IL6 in human head and neck squamous cell carcinoma cell lines that express pro-inflammatory and pro-angiogenic cytokines.

  1999cites this paper
• Oncoprotein Transforming Activities of the v-Rel for the Transcriptional , Antiapoptotic , and Mapping of a Serine-Rich Domain Essential

  1998cites this paper
• Loss of IκBα-Mediated Control over Nuclear Import and DNA Binding Enables Oncogenic Activation of c-Rel

  1998cites this paper
• Rel/NF-kappa B and I kappa B factors in oncogenesis.

  1997cites this paper